13-36867298-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001127217.3(SMAD9):​c.756T>C​(p.His252His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0043 in 1,550,138 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0036 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0044 ( 21 hom. )

Consequence

SMAD9
NM_001127217.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.498

Publications

1 publications found
Variant links:
Genes affected
SMAD9 (HGNC:6774): (SMAD family member 9) The protein encoded by this gene is a member of the SMAD family, which transduces signals from TGF-beta family members. The encoded protein is activated by bone morphogenetic proteins and interacts with SMAD4. Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010]
SMAD9 Gene-Disease associations (from GenCC):
  • pulmonary arterial hypertension
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • pulmonary hypertension, primary, 2
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • heritable pulmonary arterial hypertension
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 13-36867298-A-G is Benign according to our data. Variant chr13-36867298-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 227077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.498 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00361 (550/152284) while in subpopulation AMR AF = 0.00785 (120/15294). AF 95% confidence interval is 0.00671. There are 1 homozygotes in GnomAd4. There are 245 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 550 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001127217.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMAD9
NM_001127217.3
MANE Select
c.756T>Cp.His252His
synonymous
Exon 4 of 7NP_001120689.1
SMAD9
NM_001378621.1
c.671-1540T>C
intron
N/ANP_001365550.1
SMAD9
NM_005905.6
c.671-1540T>C
intron
N/ANP_005896.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMAD9
ENST00000379826.5
TSL:5 MANE Select
c.756T>Cp.His252His
synonymous
Exon 4 of 7ENSP00000369154.4
SMAD9
ENST00000350148.10
TSL:1
c.671-1540T>C
intron
N/AENSP00000239885.6
SMAD9
ENST00000399275.7
TSL:1
n.*381-1540T>C
intron
N/AENSP00000382216.3

Frequencies

GnomAD3 genomes
AF:
0.00361
AC:
550
AN:
152166
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000869
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00786
Gnomad ASJ
AF:
0.00893
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00506
Gnomad OTH
AF:
0.00479
GnomAD2 exomes
AF:
0.00364
AC:
569
AN:
156490
AF XY:
0.00333
show subpopulations
Gnomad AFR exome
AF:
0.000379
Gnomad AMR exome
AF:
0.00454
Gnomad ASJ exome
AF:
0.00753
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000475
Gnomad NFE exome
AF:
0.00562
Gnomad OTH exome
AF:
0.00684
GnomAD4 exome
AF:
0.00437
AC:
6113
AN:
1397854
Hom.:
21
Cov.:
29
AF XY:
0.00432
AC XY:
2977
AN XY:
689490
show subpopulations
African (AFR)
AF:
0.000729
AC:
23
AN:
31566
American (AMR)
AF:
0.00431
AC:
154
AN:
35696
Ashkenazi Jewish (ASJ)
AF:
0.00807
AC:
203
AN:
25166
East Asian (EAS)
AF:
0.0000280
AC:
1
AN:
35724
South Asian (SAS)
AF:
0.000720
AC:
57
AN:
79192
European-Finnish (FIN)
AF:
0.000325
AC:
16
AN:
49274
Middle Eastern (MID)
AF:
0.00544
AC:
31
AN:
5694
European-Non Finnish (NFE)
AF:
0.00498
AC:
5364
AN:
1077580
Other (OTH)
AF:
0.00455
AC:
264
AN:
57962
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
246
492
738
984
1230
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
206
412
618
824
1030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00361
AC:
550
AN:
152284
Hom.:
1
Cov.:
32
AF XY:
0.00329
AC XY:
245
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.000866
AC:
36
AN:
41558
American (AMR)
AF:
0.00785
AC:
120
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00893
AC:
31
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4822
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10616
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00506
AC:
344
AN:
68024
Other (OTH)
AF:
0.00474
AC:
10
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
28
57
85
114
142
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00472
Hom.:
2
Bravo
AF:
0.00403
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 20, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SMAD9: BP4, BP7, BS2

Pulmonary hypertension, primary, 2 Benign:2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 18, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Dec 09, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.His252His in exon 4 of SMAD9: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 0.6% (49/8748) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broa dinstitute.org; dbSNP rs146836873).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
5.8
DANN
Benign
0.38
PhyloP100
-0.50
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146836873; hg19: chr13-37441435; API